Addex Therapeutics Q3 EPS $(1.50) Up From $(2.77) YoY, Sales $62.500K Down From $68.161K YoY

Addex Therapeutics (NASDAQ:ADXN) reported quarterly losses of $(1.50) per share. This is a 45.85 percent increase over losses of $(2.77) per share from the same period last year. The company reported $62.500 thousand in sales this quarter. This is a 8.31 percent decrease over sales of $68.161 thousand the same period last year.